<DOC>
	<DOC>NCT02736383</DOC>
	<brief_summary>To determine if TXA utilization is effective at reducing transfusion rates in elderly patients undergoing surgery for treatment of a hip fractures.</brief_summary>
	<brief_title>Tranexamic Acid in Hip Fracture Surgery</brief_title>
	<detailed_description>Participants will be randomized to one of two groups: the intervention group and the control group. Participants will be enrolled in the study for 6 weeks.</detailed_description>
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Acute, isolated, unilateral femoral neck, intertrochanteric, and per trochanteric hip fractures confirmed by anteroposterior/lateral hip radiographs, computed tomography, or magnetic resonance imaging. Age 65 and older Low energy mechanism of injury Hip fracture fixation performed within 48 hours English speaking Anticipated medical optimization for operative fixation No other major trauma Unable to provide informed consent (dementia, limited decision making capacity) Admitted by medical service for significant comorbidities Unable or refusal to receive blood products Retained hardware around the affected hip Infection around the affected hip Transfer patients with a length of stay &gt; 24 hours at the transferring hospital History of deep vein thrombosis (DVT) or pulmonary embolus (PE) within the past year On anticoagulation treatment for DVT or PE, currently or within the past 12 months Diagnosis of deficient natural anticoagulation Known congenital thrombophilia (Deficiency of Protein C, S, Antithrombin) Known allergy to TXA History of seizure disorder Cardiac stent or ischemic stroke within 1 year Concomitant subarachnoid hemorrhage Active intravascular clotting Prisoner Patients undergoing percutaneous pinning of the hip fracture Patients with renal impairment (serum creatinine &gt;1.5 or creatinine clearance &lt; 50 ml/min)</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>